Stock Quote

Anji Pharma raises $70M as it explores going public in early 2022

At just three years old, Anji already has multiple drugs in mid- and late-stage clinical trials. The startup has just raised $70 million, which it will use to wrap up some of those trials, hire in Massachusetts and prepare for the public markets.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.